US FDA Approves Aurobindo Pharma’s Osteoarthritis Drug

Aurobindo Pharma’s, Aurolife Pharma LLC, has been granted final approval to manufacture and market Diclofenac Sodium Topical Solution by the US Food and Drug Administration (FDA). Horizon Therapeutics Ireland DAC (Horizon)’s Pennsaid Topical Solution, a reference listed drug (RLD), and the approved product are bioequivalent and therapeutically comparable. Osteoarthritis can be treated with Diclofenac Sodium […]

Continue Reading

US FDA Announced, Blood Pressure Medicine Recalled Due to Potential Cancer Risk

The US Food and Drug Administration (FDA), announced that the pharmaceutical company Aurobindo Pharma is recalling a blood pressure medication because of a potential cancer risk. The company is recalling two lots of quinapril and hydrochlorothiazide tablets because of the levels of nitrosamine. The tablets are most commonly prescribed for the treatment of hypertension to […]

Continue Reading